Relistor 12 MG/0.6 ML syringe 0.6ML
Ended Awarded
- Contract number
- SPE2DB26FX4GF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,303
Award facts
- Contract value 100% obligated
- $10,302.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Relistor 12 mg/0.6 mL syringes with a ceiling value of $10,302.56. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. As a child contract, this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion and extending through December 2026, which serves as the primary vehicle for pharmaceutical supply to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio with the Defense Logistics Agency. The company's DLA contract vehicle enables it to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Relistor, a medication used to manage opioid-induced constipation, exemplifies the company's role in providing specialized pharmaceutical solutions to the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB26FX4GF?
SPE2DB26FX4GF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FX4GF worth?
The government has obligated $10,303 on SPE2DB26FX4GF.
Is contract SPE2DB26FX4GF an order under another contract?
Yes. SPE2DB26FX4GF is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4GF competed?
The extent of competition for SPE2DB26FX4GF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award